ADCY10 frameshift variant leading to severe recessive asthenozoospermia and segregating with absorptive hypercalciuria.
Adenylyl Cyclases
/ genetics
Adult
Asthenozoospermia
/ diagnosis
Calcium
/ urine
Consanguinity
Cyclic CMP
/ analogs & derivatives
DNA Mutational Analysis
Frameshift Mutation
Homozygote
Humans
Hypercalciuria
/ diagnosis
Iran
Karyotyping
Kidney Calculi
/ diagnosis
Male
Pedigree
Sperm Motility
/ drug effects
Treatment Outcome
ADCY10
absorptive hypercalciuria
asthenozoospermia
familial exome sequencing
male infertility
Journal
Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199
Informations de publication
Date de publication:
04 06 2019
04 06 2019
Historique:
received:
19
01
2019
revised:
18
02
2019
accepted:
13
03
2019
pubmed:
24
5
2019
medline:
16
7
2020
entrez:
24
5
2019
Statut:
ppublish
Résumé
Can whole exome sequencing (WES) reveal a novel pathogenic variant in asthenozoospermia in a multiplex family including multiple patients? Patients were discovered to be homozygous for a rare 2-bp deletion in the ADCY10 coding region (c.1205_1206del, rs779944215). ADCY10 encodes for soluble adenylyl cyclase (sAC), which is the predominant adenylate cyclase in sperm. It is already established that proper sAC activity and a constant supply of cAMP are crucial to sperm motility regulation, and knockout mouse models have been reported as severely asthenozoospermic. ADCY10 is a susceptibility gene for dominant absorptive hypercalciuria (OMIM#143870); however, no ADCY10 variations have been confirmed to cause human asthenozoospermia to date. This was a retrospective genetics study of a highly consanguineous pedigree of asthenozoospermia. The subject family was recruited in Iran in 2016. The two patients were diagnosed as asthenozoospermic through careful clinical investigations. Both patients, respective parents, and an unaffected brother were subjected to WES. The discovered variant was validated by Sanger sequencing and segregated with the phenotype. To confirm the pathogenicity of the variant, sperm samples from both patients, 10 normozoospermic men and 10 asthenozoospermic patients not representing the variation, were treated with a cAMP analogue dissolved in human tubal fluid medium, followed by computer-assisted sperm analysis and statistical analyses. The discovered homozygous variant occurs at 10 amino acids upstream of the ADCY10 nucleotide binding site leading to a premature termination (p.His402Argfs*41). Treatment of the patients' sperm samples with a cell-permeable cAMP analogue resulted in a significant increase in sperm motility, indicating the pathogenic role of the variant. Moreover, absorptive hypercalciuria, segregating within the family, was also associated with the same variant following a dominant inheritance. Though nonsense-mediated decay is highly likely to occur in the mutated transcripts, we were not able to confirm this due to low RNA levels in mature sperm. Our finding enlarges the phenotypic spectrum associated with the ADCY10 gene, previously described as a susceptibility gene for dominant absorptive hypercalciuria. This study was supported by grants from the Royan Institute, Tehran, Iran, and San Raffaele Hospital, Milan, Italy. The authors have no conflict of interest. N/A.
Identifiants
pubmed: 31119281
pii: 5492390
doi: 10.1093/humrep/dez048
doi:
Substances chimiques
Cyclic CMP
3616-08-8
dibutyryl cyclic-3',5'-cytidine monophosphate
64649-87-2
ADCY10 protein, human
EC 4.6.1.1
Adenylyl Cyclases
EC 4.6.1.1
Calcium
SY7Q814VUP
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1155-1164Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.